Thirdhand Smoke Contamination in a Neonatal Intensive Care Unit (NICU)
- Conditions
- Nicotine Exposure
- Interventions
- Drug: 2% Chlorohexidine Gluconate soapDrug: 62% ethyl alcohol-based hand sanitizer
- Registration Number
- NCT04155697
- Brief Summary
The purpose of the study is to quantify the efficacy of hand washing (HW) and ethyl alcohol-based hand sanitizer (S) for third-hand smoke (THS) removal in a sub-sample of non-staff smokers using nicotine wipes on adjacent fingers before and after HW/S.
The hypotheses are that detectable levels of surface nicotine will remain on participants' fingers, regardless of hand washing (HW) and ethyl alcohol-based hand sanitizer (S) attempts and that greater finger levels of surface nicotine will remain after alcohol sanitization compared to hand washing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
Not provided
- Unwilling to comply with research procedures (i.e., finger wipes)
- Does not speak English.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hand washing with soap for thirdhand smoke removal 2% Chlorohexidine Gluconate soap - Ethyl alcohol-based sanitizer for thirdhand smoke removal 62% ethyl alcohol-based hand sanitizer -
- Primary Outcome Measures
Name Time Method Nicotine level on finger #2 5 minutes after hand washing or sanitizing Nicotine will be sampled from one finger of each participant's dominant hand (thumb, index, or middle finger). Finger will be wiped and nicotine level will be quantified.
Nicotine level on finger #1 baseline Nicotine will be sampled from one finger of each participant's dominant hand (thumb, index, or middle finger). Finger will be wiped and nicotine level will be quantified.
Nicotine level on finger #3 1 hour after hand washing or sanitizing Nicotine will be sampled from one finger of each participant's dominant hand (thumb, index, or middle finger). Finger will be wiped and nicotine level will be quantified.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States